Clinical Trial Update: Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on sequential treatment using extracorporeal shock wave therapy plus autologous bone marrow mesenchymal stem cells for ischemic heart di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Drugs mentioned

• Autologous bone marrow mesenchymal stem cells (mesenchymal stem cells)
• Extracorporeal Shock Wave Therapy

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Ischemic Heart Disease | Phase 1, Phase 2 | Status: UNKNOWN